4 ms·
Yet one of the most profitable drug launches ever was a cure for hepatitis C.
by refurb 7y ago
Yet one of the most profitable drug launches ever was a cure for hepatitis C.
- PhantomGremlin 7y agoFlash in the pan revenues. No company wants to have this press: Gilead Sciences Inc. will continue to feel the financial sting this year of declining revenues from its hepatitis C business, forecasting combined 2018 sales of the drugs reaching only a fifth of what the biotech recorded at the height of its commercial success three years ago. https://www.biopharmadive.com/news/gilead-hepatitis-c-revenues-slide-fourth-quarter-earnings/516494/ https://www.biopharmadive.com/news/gilead-hepatitis-c-revenu... Contrast a statin for Pfizer: $125 billion in sales over 14 years. Lipitor alone "provided up to a quarter of Pfizer Inc.'s annual revenue for years." https://en.wikipedia.org/wiki/Atorvastatin#History https://en.wikipedia.org/wiki/Atorvastatin#History
- refurb 7y agoYeah, a company would certainly turn down a $10B a year drug because revenues declined after a few years! Sure it’s not as successful as Lipitor (pretty much the most successful drug ever), but it’s total sales DWARF 95% of the drugs out there.
- verucanacl 7y agoFor good reason. Curing Hep C was a breakthrough medical innovation, which ultimately will save the healthcare system tens of billions of dollars (preventing end stage liver disease, liver transplants, etc)